FDA — authorised 27 September 2018
- Marketing authorisation holder: ELI LILLY AND CO
- Status: approved
🇺🇸 Emgality in United States
FDA authorised Emgality on 27 September 2018
Marketing authorisations
FDA — authorised 27 September 2018
- Application: BLA761063
- Marketing authorisation holder: ELI LILLY AND CO
- Local brand name: EMGALITY
- Indication: INJECTABLE — INJECTION
- Status: approved
Emgality in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Emgality approved in United States?
Yes. FDA authorised it on 27 September 2018; FDA authorised it on 27 September 2018.
Who is the marketing authorisation holder for Emgality in United States?
ELI LILLY AND CO holds the US marketing authorisation.